ConductScience.org, home

Paper219669

Sendai virus.

Ishida N and 1 other. Adv Virus Res, 1978. Cited by 82 papers, by iCite.

Cite this record

ConductScience Library. Sendai virus. Papers, record 219669. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/219669

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Sendai virus.
PubMed
Journal
Adv Virus Res
PubMed
Year
1978
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
82
iCite
Relative citation ratio, by iCite
2.11
iCite
Revised in PubMed
2019-10-28
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ishida NN
2Homma MM

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
GlycoproteinsMajor topic
Parainfluenza Virus 1, HumanMajor topic
Paramyxoviridae InfectionsMajor topic
Viral ProteinsMajor topic
Animals
Cell Fusion
Chick Embryo
Hemagglutinins, Viral
Hemolysis
Male
Mice
Models, Biological
Neuraminidase
Trypsin

Source PubMed

Download CSV of topics

Cited by42

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 82 citations.

PMIDTitleJournalYearIn PapersSource
40431748Recombinant Sendai Virus Vectors as Novel Vaccine Candidates Against Animal Viruses.Viruses2025https://conductscience.org/library/papers/40431748PubMed
40333329Intranasal Sendai Virus Vaccination of Seropositive Children 1 to 2 Years of Age in a Phase I Clinical Trial Boosts Immune Responses Toward Human Parainfluenza Virus Type 1.Vaccines (Basel)2025https://conductscience.org/library/papers/40333329PubMed
37847710A potent MAPK13-14 inhibitor prevents airway inflammation and mucus production.Am J Physiol Lung Cell Mol Physiol2023https://conductscience.org/library/papers/37847710PubMed
34072332Sendai Virus-Vectored Vaccines That Express Envelope Glycoproteins of Respiratory Viruses.Viruses2021https://conductscience.org/library/papers/34072332PubMed
33441338Mechanisms and consequences of Newcastle disease virus W protein subcellular localization in the nucleus or mitochondria.J Virol2021https://conductscience.org/library/papers/33441338PubMed
30547053Quantification of Infectious Sendai Virus Using Plaque Assay.Bio Protoc2018https://conductscience.org/library/papers/30547053PubMed
30370318Sendai Virus Propagation Using Chicken Eggs.Bio Protoc2018https://conductscience.org/library/papers/30370318PubMed
30352599RIG-I is responsible for activation of type I interferon pathway in Seneca Valley virus-infected porcine cells to suppress viral replication.Virol J2018https://conductscience.org/library/papers/30352599PubMed
30209189Influenza A Virus Infection Causes Chronic Lung Disease Linked to Sites of Active Viral RNA Remnants.J Immunol2018https://conductscience.org/library/papers/30209189PubMed
26648515Sendai virus as a backbone for vaccines against RSV and other human paramyxoviruses.Expert Rev Vaccines2016https://conductscience.org/library/papers/26648515PubMed
21750677Illumination of parainfluenza virus infection and transmission in living animals reveals a tissue-specific dichotomy.PLoS Pathog2011https://conductscience.org/library/papers/21750677PubMed
20682364Robust IgA and IgG-producing antibody forming cells in the diffuse-NALT and lungs of Sendai virus-vaccinated cotton rats associate with rapid protection against human parainfluenza virus-type 1.Vaccine2010https://conductscience.org/library/papers/20682364PubMed
19200447Human PIV-2 recombinant Sendai virus (rSeV) elicits durable immunity and combines with two additional rSeVs to protect against hPIV-1, hPIV-2, hPIV-3, and RSV.Vaccine2009https://conductscience.org/library/papers/19200447PubMed
18844597Pulmonary immunity and immunopathology: lessons from respiratory syncytial virus.Expert Rev Vaccines2008https://conductscience.org/library/papers/18844597PubMed
16051860
An S101P substitution in the putative cleavage motif of the human metapneumovirus fusion protein is a major determinant for trypsin-independent growth in vero cells and does not alter tissue tropism in hamsters.
J Virol2005https://conductscience.org/library/papers/16051860PubMed
15834752Mutations in Sendai virus variant F1-R that correlate with plaque formation in the absence of trypsin.Med Microbiol Immunol2005https://conductscience.org/library/papers/15834752PubMed
15141002Recombinant Sendai virus expressing the G glycoprotein of respiratory syncytial virus (RSV) elicits immune protection against RSV.J Virol2004https://conductscience.org/library/papers/15141002PubMed
12829830Sendai virus targets inflammatory responses, as well as the interferon-induced antiviral state, in a multifaceted manner.J Virol2003https://conductscience.org/library/papers/12829830PubMed
10400752Sendai virus C proteins counteract the interferon-mediated induction of an antiviral state.J Virol1999https://conductscience.org/library/papers/10400752PubMed
10074164Sendai virus and simian virus 5 block activation of interferon-responsive genes: importance for virus pathogenesis.J Virol1999https://conductscience.org/library/papers/10074164PubMed

See all 42 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/219669

GET https://conductscience.org/api/papers/v1/219669/cited_by?page=2